Gaetano Aurilio

Ripamonti Street 435
Milan, 20141, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2026

177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.

177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 12, 2025

Molecular tumour board in gastrointestinal cancers.

Molecular tumour board in gastrointestinal cancers.

Journal: ESMO open

Published: January 21, 2025

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.

Journal: Genes

Published: November 27, 2024

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study.

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study.

Journal: European urology oncology

Published: October 02, 2024

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.

Journal: Targeted oncology

Published: September 01, 2024

Molecular tumor board in patients with metastatic breast cancer.

Molecular tumor board in patients with metastatic breast cancer.

Journal: Breast cancer research and treatment

Published: August 27, 2024

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

Journal: NPJ breast cancer

Published: August 09, 2024

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.

Journal: PloS one

Published: August 05, 2024

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Journal: Cancer immunology, immunotherapy : CII

Published: February 05, 2024

Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity.

Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity.

Journal: European journal of radiology

Published: December 30, 2023

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.

Journal: Minerva urology and nephrology

Published: August 02, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026